ClinicalTrials.Veeva

Menu

Home Treatment for Individuals Suffering From Severe Addictive Disorders

L

Louise Penzenstadler

Status

Enrolling

Conditions

Substance Use Disorders

Treatments

Other: standard inpatient treatment
Other: Hospital-like treatment in patients' home

Study type

Interventional

Funder types

Other

Identifiers

NCT05563363
not yet available (Other Identifier)

Details and patient eligibility

About

Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted.

The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Substance use disorder
  • age 18 or above
  • sufficient french language skills
  • competent subjects
  • consent to randomization progress

Exclusion criteria

  • organic brain disease or developmental disorder
  • non voluntary admission
  • severe somatic comorbidity
  • History of complicated substance withdrawal
  • acute suicidal ideation
  • aggressive behavior
  • acute psychiatric disease such as mania or psychosis
  • distance to center (must be reachable within 60 minutes)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Home treatment
Experimental group
Description:
Home visits by care staff at the same frequency as in hospital
Treatment:
Other: Hospital-like treatment in patients' home
Standard inpatient treatment
Active Comparator group
Description:
Inpatient treatment on hospital ward
Treatment:
Other: standard inpatient treatment

Trial contacts and locations

1

Loading...

Central trial contact

Louise Penzenstadler, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems